Suk Kyoon Yoon
Overview
Explore the profile of Suk Kyoon Yoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Chin J, Im C, Yoo E, Woo S, Hwang H, et al.
Eur J Med Chem
. 2016 May;
120:338-52.
PMID: 27236015
Estrogen-related receptor gamma (ERRγ) has recently been recognized as an attractive target for treating inflammation, cancer, and metabolic disorders. Herein, we discovered and demonstrated the in vitro pharmacology as well...
2.
Song M, Kim S, Yoon S
Arch Pharm Res
. 2015 Sep;
38(12):2120-3.
PMID: 26377589
A new chimeric fusion transcript of KIF5B (the kinesin family 5B gene) and the RET (Rearranged during Transcription) oncogene, KIF5B-RET, was found in 1-2% of lung adenocarcinomas (LADCs) in 2012....
3.
Kim J, Lee S, Boyce M, Warrington S, Cho K, Yoon S, et al.
Xenobiotica
. 2015 Feb;
45(8):663-71.
PMID: 25673087
1. The safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of LB30870, a new selective thrombin inhibitor, were studied in 16 healthy men. 2. A double-blind, placebo-controlled single ascending dose study...
4.
Lee K, Park C, Jung W, Park H, Lee S, Chung K, et al.
J Med Chem
. 2003 Aug;
46(17):3612-22.
PMID: 12904065
Thrombin, a crucial enzyme in the blood coagulation, has been a target for antithrombotic therapy. Orally active thrombin inhibitors would provide effective and safe prophylaxis for venous and arterial thrombosis....